Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11241 clinical trials
test cancer API Toggle On

See protocol section 2 See protocol section 2 See protocol section 2. this is p tag. header

  • 0 views
  • 20 Feb, 2026
  • 1 location
Lorlatinib Combinations in Lung Cancer

This research study is evaluating Lorlatinib in combination with Crizotinib or Binimetinib as a possible treatment for either anaplastic lymphoma kinase (ALK)-positive lung cancer or ROS1-positive lung cancer. This research study involves three study drugs. Lorlatinib Binimetinib Crizotinib

lorlatinib
immunohistochemistry
lacosamide
crizotinib
major surgery
  • 0 views
  • 16 Feb, 2024
  • 2 locations
TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

This phase II trial studies how well TAS-102 and oxaliplatin work in treating patients with stage IV colon cancer. Drugs used in chemotherapy, such as TAS-102 and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or …

colon cancer
neutrophil count
EGFR
stage iva colon cancer
colon carcinoma
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Ipatasertib + Atezolizumab to Prevent Recurrence in TNBC

The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer in the breast or lymph nodes and have circulating tumor DNA in the blood. This research study involves the following investigational drugs: Ipatasertib Atezolizumab

immunostimulant
immunohistochemistry
colony stimulating factor
bisphosphonate
cfdna
  • 0 views
  • 16 Feb, 2024
  • 1 location
cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation

The objective is to screen and monitor the efficacy of cfDNA methylation in patients with stage I lung cancer after ablation, to compare the similarities and differences of cfDNA methylation between surgical treatment and ablation in patients with stage I lung cancer, and to look for new indicators to assess …

ct scan chest
cfdna
lung cancer
chest ct
cancer
  • 0 views
  • 05 Aug, 2020
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Control arm will be paclitaxel in combination with cetuximab, treatment included in the guidelines of the Spanish Society of Medical Oncology.

pulmonary disease
vitiligo
cetuximab
pneumonitis
liver metastasis
  • 0 views
  • 16 Feb, 2024
  • 20 locations
Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities

This phase I/II trial studies the side effects and best dose of cabozantinib when given with radiation therapy and how well it works in treating patients with sarcoma of the extremities. Cabozantinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving …

neutrophil count
colony-stimulating factors
oral contraceptives
bone metastases
sarcoma
  • 0 views
  • 16 Feb, 2024
  • 1 location
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

Participating in the program may improve knowledge and confidence about follow-up care, communication with cancer care and primary care doctors, and quality of life after cancer treatment in non-small cell lung cancer or colorectal cancer survivors.

stage ii colorectal cancer ajcc v8
stage iia lung cancer ajcc v8
stage iia colorectal cancer ajcc v8
stage iib lung cancer ajcc v8
lung cancer
  • 4 views
  • 16 Feb, 2024
  • 1 location
Combination Immunotherapy Targeting Sarcomas

The aim of this clinical trial is to assess the feasibility, safety and efficacy of a combination low dose chemotherapy and immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy that combines …

steroid hormone
renal function
immunosuppressive agents
pulse oximetry
sarcoma
  • 0 views
  • 16 Feb, 2024
  • 2 locations
CIML NK Cell in Head & Neck Cancer

This research study is evaluating the safety and efficacy of a combination drug and biologic therapy in patients with advanced head and neck cancer. This research study involves the following drugs and biologics: CIML NK donor cells IL-15 superagonist Ipilimumab

immunohistochemistry
oropharyngeal
neutrophil count
metastatic squamous cell carcinoma
biological therapy
  • 0 views
  • 16 Feb, 2024
  • 1 location